Cerenome, Inc.

CNSY ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-23.2M
Depreciation & Amortization $1.7M
Depreciation —
Amortization —
Stock-Based Compensation $2.6M
Net Cash from Operating Activities $-23.8M
Investing Activities
Capital Expenditures $221.0K
Business Acquisitions —
Net Cash from Investing Activities $-221.0K
Financing Activities
Dividends Paid —
Stock Repurchases —
Net Cash from Financing Activities $24.3M
Net Change in Cash $243.0K
Free Cash Flow $-24.0M
← Newer Page 3 of 3 Older →